Virometix CEO Anna Sumeray
Virometix CEO Anna Sumeray

Next-generation nanoparticle vaccine technology directed to scale up in Asia

  • Vaccine biotechnology company Virometix is preparing to raise fund, and is seeking industry collaborations in oncology, autoimmune diseases and allergy treatments

Virometix CEO Anna Sumeray
Virometix CEO Anna Sumeray
READ FULL ARTICLE